US 9212149
Substituted 2-amidoquinazol-4-ones as matrix metalloproteinase-13 inhibitors
granted A61PA61P19/02A61P29/00
Quick answer
US patent 9212149 (Substituted 2-amidoquinazol-4-ones as matrix metalloproteinase-13 inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61P, A61P19/02, A61P29/00, A61P43/00